Abstract
The invention provides a compound represented by structural formula (I): or a pharmaceutically acceptable salt, or a stereoisomer thereof useful for treating cancer.
Full Text
What is claimed is:
The invention provides a compound represented by structural formula (I):
or a pharmaceutically acceptable salt, or a stereoisomer thereof useful for treating cancer.
Timeline
Filed
05/04/2026Published
09/10/2026Granted
Not AvailableIPC Codes(8)
A61K 31/506:not condensed and containing further heterocyclic rings
A61K 31/5377:not condensed and containing further heterocyclic rings, e.g. timolol
A61K 31/55:having seven-membered rings, e.g. azelastine, pentylenetetrazole